Industries > Pharma > Medical Device Leader Series: Top Pre-Filled Injection Device Manufacturers 2019-2029

Medical Device Leader Series: Top Pre-Filled Injection Device Manufacturers 2019-2029

Profiles, R&D and Revenue Forecasting for Leading Syringe, Injector and Component Producers and Contract Filling Services

PUBLISHED: 30 August 2019
PAGES: 224
PRODUCT CODE: PHA0521
SUBMARKET: Medical Devices

Clear
WOOCS 2.2.1

The Pre-Filled Device Manufacturing market is estimated to reach $8.3bn in 2024, growing at a CAGR of 9.5% throughout the forecast period.

The majority of revenues for pre-filled syringe manufacturers, including component manufacturers and pen injector/autoinjector manufacturers, came from developed markets.

How this 224-page report delivers:

• Provides an overview and revenue forecasts of the global pre-filled injectable devices market from 2019 to 2029

• Profiles of selected leading companies in the pre-filled injection device manufacturing:
• Leading pre-filled syringe manufacturers
• Leading pre-filled injectable component manufacturers
• Leading pen injector and autoinjector manufacturers
• Leading pre-filled injectable devices contract manufacturers

• Companies profiled in this report:
• Aptar Stelmi
• Becton, Dickinson, & Co (BD)
• Bespak Injectables
• Boehringer Ingelheim
• Catalent
• Dätwyler Holding
• Gerresheimer
• Haselmeier
• Laboratorios Farmacéuticos ROVI
• Nemera.
• Nipro
• Ompi
• Owen Mumford
• Roselabs Group.
• Schott
• SHL Group
• Tip-top
• Vetter Pharma
• Weigao Group Pharmaceutical Packaging Products Company
• West Pharmaceutical Services.
• Ypsomed

Top Pre-Filled Injection Device Manufacturers 2019-2029

• Information provided for the selected leading companies, when available:
• Overview of the company
• Historical Revenues
• Revenue forecasts from 2019-2029
• A SWOT analysis
• A competitive analysis
• Products & Services
• Business Developments: Expansion, new products, mergers, acquisitions, collaborations.

• This report also discusses the key trends in the pre-filled injection device manufacturing market.

109 charts unavailable elsewhere

Visiongain’s study is intended for anyone requiring commercial analyses for the pre-filled injection device manufacturing market. You find data, trends and predictions.

Buy our report today Top Pre-Filled Injection Device Manufacturers 2019-2029: Profiles, R&D and Revenue Forecasting for Leading Syringe, Injector and Component Producers and Contract Filling Services.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Medical Device Leader Series: Top Pre-Filled Injection Device Manufacturers 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Medical Device Leader Series: Top Pre-Filled Injection Device Manufacturers 2019-2029


Latest Pharma news

Visiongain Publishes Checkpoint Inhibitors for Treating Cancer Market Report 2021-2031

We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

29 July 2021

READ

Visiongain Publishes Direct-to-Patient Market Report 2021-2031

Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.

21 July 2021

READ

Visiongain Publishes Drug Delivery Technologies Market Report 2021-2031

Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.

20 July 2021

READ

Visiongain Publishes Pharma Contract Sales Market Report 2021-2031

Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.

14 July 2021

READ

Categories